What You Should Know:
- Castor raises $12M in Series A funding to further their
support for COVID-19 research through clinical trial and data automation.
- With 4,000 live studies and 2,000,000 enrolled patients
across 90 countries, Castor will use the funding to further invest in enabling
patient-centric, data-powered clinical trials.
Castor, a Hoboken,
New Jersey startup using automation and data reuse to simplify the entire
clinical trial process, announced $12M in Series A
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
THREAD Lands $50M for Decentralized Clinical Trial Research Platform
What You Should Know:
- THREAD receives an additional $50 million capital commitment from Water Street and JLL Partners to expand its decentralized clinical trial research platform
- THREAD is an innovative technology and service
provider that increases participant engagement by enabling pharmaceutical
companies and contract research organizations to remotely capture data from
participants and sites during, in between and in lieu of in-clinic
visits.
- This major investment
Read More
Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform
What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
Bayer, Verizon Partner to Build Next-Gen Global Network Infrastructure
What You Should Know:
- Bayer announced that it has chosen Verizon
Business to build a next-gen global network infrastructure to support the
pharmaceutical giant’s global business operations.
- Verizon will enhance Bayer’s existing network
capabilities to enable easier and more cost-effective network management and
will deploy next-generation network technologies, such as software-defined
networking (SDN), to further improve resilience, flexibility,
Read More
Reify Health Raises $30M to Fix The Broken Clinical Trial Ecosystem
What You Should Know:
- Reify Health, a clinical trial software provider
that digitizes and accelerates clinical trials is announcing a $30 million
series B funding round to support the company’s ambitious mission to fix the
broken clinical trial ecosystem.
- The company’s platform, StudyTeam systematically
eliminates redundant work across the clinical trial process while generating
novel insights that speed up trials.
StudyTeam harmonizes biopharma and research
Read More
Moderna Leverages AWS Cloud Platform to Develop New Class of Vaccines and Therapeutics
What You Should Know:
- Moderna, Inc., a biotechnology company pioneering a new
class of messenger RNA (mRNA) medicines, has selected Amazon Web Services
(AWS) as its preferred cloud provider, as well as its standard for
analytics and machine learning workloads.
- By building and scaling its operations on AWS, Moderna
is able to quickly design research experiments and uncover new insights,
automate its laboratory and manufacturing processes to enhance its drug
discovery
Read More
Talis Awarded $25M NIH Contract for Point-of-Care COVID-19 Testing
What You Should Know:
- Today, Talis Biomedical Corporation announced it has
been awarded a $25M contract from the National Institutes of Health (NIH) as
part of Phase 2 of its Rapid Acceleration of Diagnostics (RADx) initiative as
well as another $100 million in additional financing.
- The new funding will be used to scale manufacturing for
the launch of the Talis One™ diagnostic platform that provides rapid and highly
accurate detection of COVID-19 at points-of-care in 30 minutes
Read More
Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap
Secondary bacterial or fungal co-infections in COVID-19 patients have received inadequate attention from the public. For most, co-infections pose little to no risk according to reports that an estimated 8% of patients are found to experience this during hospital admission – a relatively low number compared to the global impact of the virus. However, once a patient enters a hospital for care or becomes ventilated while in the ICU, the risk for acquiring and spreading a deadly
Read More
COVID-19 Molecular Test Shipments Top One Million Per Day
The Advanced Medical Technology Association (AdvaMed) today announced that shipments of COVID-19 molecular diagnostic tests reached one million per day for the week ending July 24, based on the latest data from the association's National Testing Registry.
"This incredible milestone is just the latest example of how the medical technology industry is rising to meet the challenges posed by the COVID-19 pandemic," said Scott Whitaker, AdvaMed president and CEO. "Widespread and widely available
Read More
Fujifilm Sonosite Unveils Next-Gen Point-of-Care Ultrasound System for Frontline Clinicians
What You Should Know:
- FUJIFILM Sonosite, Inc. launches its next-generation point-of-care (POCUS) ultrasound system - designed specifically for the clinicians on the front lines of medicine to treat patients more effectively.
- The
product is expected to commercialize in the US, Australia and New Zealand in
July 2020, and in the UK, Spain, Germany and France this August. Sonosite has
received nearly 600 leads (and counting) from healthcare providers and medical
facilities in the U.S.
Read More
